Baseline characteristics included a mean Parkinson disease duration of 11.8 years and a mean levodopa daily dose of 695mg PHILADELPHIA – Long-term adjunctive amantadine (Gocovri; Adamas ...
The approval of Osmolex ER was based on bioavailability studies comparing Osmolex ER to immediate-release amantadine. Osmotica announced that the Food and Drug Administration (FDA) has approved ...
Please provide your email address to receive an email when new articles are posted on . Posttraumatic headaches improved for 80% of patients who took amantadine for 2 months after having ...
Gocovri (amantadine) is a brand-name drug prescribed to treat involuntary movements and reduce “off” episodes in adults taking a levodopa-based medication for Parkinson’s disease. Common side effects ...
A comparative analysis of inpatient Do Not Resuscitate (DNR) forms used at National Cancer Institute-designated cancer centers (NCICC) No significant financial relationships to disclose. This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results